NCT03021486 2026-03-18
Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer
M.D. Anderson Cancer Center
Phase 2/3 Active not recruiting
Clinical Trials
8 trialsNCT03743649 2025-12-26
Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care
M.D. Anderson Cancer Center
Phase 2/3 Active not recruiting
NCT04833023 2024-04-12
HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial
Tan Tock Seng Hospital
Phase 3 Recruiting
NCT06218524 2024-01-23
The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM
Southern Medical University, China
Phase 2 Not yet recruiting
NCT01298193 2023-03-07
Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.
Spanish Breast Cancer Research Group
Phase 4 Completed
NCT01539733 2017-04-07
Early Recognition and Optimal Treatment of Delirium in Patients With Advanced Cancer
Amsterdam UMC, location VUmc
Phase NA Completed
NCT01556932 2015-10-16
Randomized Trial of the Effectiveness of Topical "ABH Gel" vs. Placebo in Cancer Patients With Nausea
Virginia Commonwealth University
Phase NA Completed
NCT00124930 2012-01-19
Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer
AHS Cancer Control Alberta
Phase 3 Terminated